SCHEMBL23329185

SCHEMBL23329185

O=C(NC1CCCC1)c1cc(-c2cncs2)cc2[nH]ccc12

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CD38 P28907 18/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23304751 0.99 CD38 (0.85) CD38
SCHEMBL23329326 0.98 CD38 (0.86) CD38
SCHEMBL23329112 0.93 CD38 (1.00) CD38
SCHEMBL23329188 0.92 CD38 (0.83) CD38
Hydrochloric Acid SCHEMBL23305435 0.91 CD38 (0.82) CD38
SCHEMBL23304721 0.91 CD38 (0.82) CD38
SCHEMBL23304764 0.90 CD38 (0.80) CD38
SCHEMBL23304763 0.90 CD38 (0.80) CD38
SCHEMBL23329147 0.89 CD38 (0.85) CD38
SCHEMBL23329203 0.89 CD38 (0.85) CD38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021087087-A1 N-CYCLOHEXYL-5-(THIAZOL-5-YL)-1H-INDOLE-7-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CD38 INHIBITORS FOR INCREASING NAD+ AND FOR THE TREATMENT OF E.G. MUSCULAR DISORDERS MITOBRIDGE INC. (US) 2021-05-06 WO disclosed